HYUNDAI BIOLAND Revenue

HYUNDAI BIOLAND had revenue of 35.48B KRW in the quarter ending September 30, 2025, with 10.96% growth. This brings the company's revenue in the last twelve months to 129.68B, up 15.99% year-over-year. In the year 2024, HYUNDAI BIOLAND had annual revenue of 119.52B with 23.57% growth.

Revenue (ttm)

129.68B

Revenue Growth

+15.99%

P/S Ratio

0.97

Revenue / Employee

380.29M

Employees

341

Market Cap

126.00B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	119.52B	22.80B	23.57%
Dec 31, 2023	96.72B	-2.43B	-2.45%
Dec 31, 2022	99.15B	-3.65B	-3.55%
Dec 31, 2021	102.80B	13.90B	15.64%
Dec 31, 2020	88.90B	-17.41B	-16.38%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
H.PIO	257.56B
DongKoo Bio & Pharma	238.39B
Kyung Dong Pharmaceutical	193.64B
GREEN CROSS WellBeing	151.06B
WITHUS PHARMACEUTICAL Co.,LTD.	102.11B
KOREA PHARMA	90.11B
OPTUS Pharmaceutical	87.58B
Sam-A Pharm.	76.66B

Revenue Rankings